Stereotaxis Inc. Announces Resignation of Frank Cheng as Senior Vice President, Marketing and Business Development, Effective from November 18, 2016
November 01, 2016 at 08:02 am EDT
Share
On October 26, 2016, Frank Cheng, Senior Vice President, Marketing and Business Development, notified Stereotaxis Inc. (the company) of his decision to resign from the company effective November 18, 2016.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Companyâs primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.